PF-06305591 ( PF06305591 | PF 06305591 )

产品货号. M11932 CAS No. 1449473-97-5

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

PF-06305591
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

PF-06305591 (PF06305591) 是一种有效的、高选择性的 NaV1.8 阻断剂，IC50 为 15 nM，对其他钠通道亚型、K+ 通道和 Ca2+ 通道没有显着活性。
产品描述

PF-06305591 (PF06305591) is a potent, highly selective selective NaV1.8 blocker with IC50 of 15 nM, displays no significant activity against other sodium channel subtypes, K+ channels and Ca2+ channels; displays excellent preclinical in vitro ADME and safety profile.Pain Phase 1 Discontinued.
体外实验

PF-06305591 (compound 9) has a highly attractive profile with respect to NaV selectivity, hERG activity, passive permeability and in vitro metabolic stability.
体内实验

PF-06305591 (compound 9) has good rat bioavailability. PF-06305591 offers the possibility of investigating higher IC50 multiples of Nav1.8 blockade in the clinic, and therefore a more thorough evaluation of the role of NaV1.8 in the treatment of pain.
同义词

PF06305591 | PF 06305591
通路

Membrane Transporter/Ion Channel
靶点

Sodium Channel
受体

Sodium Channel
研究领域

Neurological Disease
适应症

Pain

CAS Number

1449473-97-5
分子量

274.368
分子式

C15H22N4O
纯度

>98% (HPLC)
溶解度

In Vitro:?DMSO : 140 mg/mL (510.28 mM)
SMILES

CC(C(C1=NC2=C(N1)C=C(C=C2)C(C)(C)C)N)C(=O)N
化学全称

(2R,3S)-3-amino-3-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)-2-methylpropanamide

1. Brown AD, et al. Bioorg Med Chem. 2019 Jan 1;27(1):230-239.

计算器

产品手册

关联产品

AZD 7009 B

AZD 7009 is a novel antiarrhythmic compound that inhibits the sodium current of hNav1.5 in CHO K1 cells with an IC50 of 11 uM. AZD 7009 inhibited late sodium current in isolated rabbit atrial and ventricular myocytes, and prolonged E-4031-induced action potential duration, promoting early post-depolarization of Purkinye fibers (EADs).
Fosphenytoin sodium

磷苯妥英是苯妥英的前药，可迅速转化为苯妥英，一种电压门控钠通道阻滞剂。
ICA-121431

ICA-121431 是一种纳摩尔级强效小分子 Nav1.7 通道抑制剂，对大鼠 Nav1.7 的 IC50 为 19 nM，对人 Nav1.5 或 Nav1.7 通道几乎没有或没有活性。